The majority of patients exhibited low levels of both GPC1+ve and GPC1-GP2+ve EVs, which is reflected by the lack of significant difference between mean EV counts for BPD, resected cancer, and metastatic cancer groups as determined through one-way ANOVA (p>0.20) (Figure 2A). Here, GPC1 is linked to metastatic malignant neoplasm.